Actively Recruiting
Safety and Efficacy of MILEP Versus Standard EEP
Led by Sechenov University · Updated on 2025-02-21
340
Participants Needed
1
Research Sites
59 weeks
Total Duration
On this page
Sponsors
S
Sechenov University
Lead Sponsor
H
Hospital Pompeia
Collaborating Sponsor
AI-Summary
What this Trial Is About
Endoscopic enucleation of the prostate (EEP) is a standard treatment for benign prostatic hyperplasia (BPH), with modifications such as MiLEP that utilizes smaller instruments. The reduced resectoscope diameter in MiLEP may help decrease rates of stress urinary incontinence (SUI) and urethral strictures. Objective: to compare the efficacy and safety of MiLEP and standard EEP with a thulium fiber laser (TFL).
CONDITIONS
Official Title
Safety and Efficacy of MILEP Versus Standard EEP
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male participants aged 18 to 85 years
- Presence of lower urinary tract symptoms confirmed by either an IPSS score greater than 20 or uroflowmetry result with Qmax less than 10 ml/s
You will not qualify if you...
- Prostate volume greater than 120 cc
- Diagnosis of prostate cancer on pathology
- Presence of urethral strictures
- Presence of bladder stones
- Prior prostate surgery
- Neurogenic bladder dysfunction
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Institute for Urology and Reproductive Health, Sechenov University
Moscow, Russia, 119435.
Actively Recruiting
Research Team
V
Vladislav Petov, Associate Professor, urologist
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here